Joonhyuk Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Joonhyuk Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Chang Jin Yoon
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
1 shared publication - Chong-Ho Lee
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea
1 shared publication Dongyeon Kim
R&D Center, IMGT Co., Ltd., Seongnam-si, Republic of Korea
1 shared publication- Hak Jong Lee
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Korea
1 shared publication - Hyeree Park
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea
1 shared publication - Jae Hwan Lee
Department of Radiology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
1 shared publication
Latest Publications
- 9 September 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (1) , 118-125
Antitumor Effects of Doxorubicin-Loaded Cellulose Nanoparticles in the Rabbit VX2 Liver Tumor Model
Purpose To evaluate the preclinical efficacy and safety of transarterial chemoembolization (TACE) using doxorubicin-loaded biocompatible cellulose nanoparticles in a rabbit VX2 liver tumor model. Materials and Methods Following institutional animal care committee approval, 23 rabbits with VX2 liver tumors were randomized into three groups: Group A (n = 9) received doxorubicin-loaded cellulose nanoparticles with ethiodized oil; Group B (n = 9) received doxorubicin with ethiodized oil; and Group C (n = 5) served as untreated controls. Tumor size was monitored via ultrasound for 4 weeks, and serum liver enzymes (aspartate transaminase and alanine transaminase) were measured on days 1, 3, and 7 to assess hepatotoxicity. An additional 10 healthy rabbits were randomized into two groups: Group D (n = 5) received doxorubicin-loaded cellulose nanoparticles with ethiodized oil, and Group E (n = 5) received doxorubicin with ethiodized oil, to measure serum doxorubicin concentrations up to 30 min post-treatment. Results Group A demonstrated significantly slower overall tumor growth compared to Group C (p = 0.005) and slower growth between days 24 and 27 compared to Group B (p = 0.037). Pharmacokinetic analysis showed significantly lower serum doxorubicin levels in Group D than Group E at 2 and 5 min post-delivery (p < 0.05). Hepatotoxicity peaked at 24 h, with significantly lower alanine transaminase levels in Group A compared to Group B (p = 0.025), normalizing by day 7. Conclusion TACE using doxorubicin-loaded cellulose nanoparticles demonstrated promising preclinical efficacy and safety compared to conventional TACE. Level of Evidence No level of evidence, Animal Study Graphical Abstract
- 9 September 2025
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 49 (1) , 118-125
Antitumor Effects of Doxorubicin-Loaded Cellulose Nanoparticles in the Rabbit VX2 Liver Tumor Model
Purpose To evaluate the preclinical efficacy and safety of transarterial chemoembolization (TACE) using doxorubicin-loaded biocompatible cellulose nanoparticles in a rabbit VX2 liver tumor model. Materials and Methods Following institutional animal care committee approval, 23 rabbits with VX2 liver tumors were randomized into three groups: Group A (n = 9) received doxorubicin-loaded cellulose nanoparticles with ethiodized oil; Group B (n = 9) received doxorubicin with ethiodized oil; and Group C (n = 5) served as untreated controls. Tumor size was monitored via ultrasound for 4 weeks, and serum liver enzymes (aspartate transaminase and alanine transaminase) were measured on days 1, 3, and 7 to assess hepatotoxicity. An additional 10 healthy rabbits were randomized into two groups: Group D (n = 5) received doxorubicin-loaded cellulose nanoparticles with ethiodized oil, and Group E (n = 5) received doxorubicin with ethiodized oil, to measure serum doxorubicin concentrations up to 30 min post-treatment. Results Group A demonstrated significantly slower overall tumor growth compared to Group C (p = 0.005) and slower growth between days 24 and 27 compared to Group B (p = 0.037). Pharmacokinetic analysis showed significantly lower serum doxorubicin levels in Group D than Group E at 2 and 5 min post-delivery (p < 0.05). Hepatotoxicity peaked at 24 h, with significantly lower alanine transaminase levels in Group A compared to Group B (p = 0.025), normalizing by day 7. Conclusion TACE using doxorubicin-loaded cellulose nanoparticles demonstrated promising preclinical efficacy and safety compared to conventional TACE. Level of Evidence No level of evidence, Animal Study Graphical Abstract
- Open Access
- 1 January 2019
- Published by XMLink in Korean Journal of Radiology
- Vol. 20 (2) , 275-282
Evaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging
Park H, et al. Korean J Radiol. 2018 Oct;20:e25. https://doi.org/10.3348/kjr.2018.0300
- 1 January 2019
- Published by XMLink in Korean Journal of Radiology
- Vol. 20 (2) , 275-282
Open AccessEvaluation of Tumor Blood Flow Using Alternate Ascending/Descending Directional Navigation in Primary Brain Tumors: A Comparison Study with Dynamic Susceptibility Contrast Magnetic Resonance Imaging
Park H, et al. Korean J Radiol. 2018 Oct;20:e25. https://doi.org/10.3348/kjr.2018.0300